besthealtharticle.com
MONDAY, Aug. 6, 2018 — The combination of digital mammography (DM) and digital breast tomosynthesis (DBT) detects 90 percent more breast cancers than digital mammography alone, according to a study published in the August issue of Radiology. Pierpaolo Pattacini, M.D., from AUSL Reggio Emilia in Italy, and colleagues compared DM to DBT+DM for breast cancer […]
Triple-negative breast cancer is a particularly aggressive form of breast cancer. Here, important receptors are missing, which often serve as targets for treatments. Thus, these tumors are unlikely to respond to current therapies. Researchers from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena now identified the protein TRPS1, which is commonly […]
(HealthDay)—The C-509T allele in the promoter region of transforming growth factor β (TGFB1) is associated with radiation-induced breast fibrosis risk among patients with early-stage breast cancer, according to study published online July 19 in JAMA Oncology. Aaron J. Grossberg, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined […]
Having an early supper or leaving an interval of at least two hours before going to bed are both associated with a lower risk of breast and prostate cancer. Specifically, people who take their evening meal before 9 p.m. or wait at least two hours before going to sleep have an approximate 20 percent lower […]
Eating dinner before 9pm or waiting at least two hours between chowing down and heading to bed has been found to reduce your risk of breast and prostate cancer by 20 percent. A new study by the Barcelona Institute for Global Health followed 621 people who had prostate cancer and 1,205 who had breast cancer, as […]
Research led by Suresh Alahari, Ph.D., Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer. The research is […]
There is a highly sophisticated way to treat some breast and ovarian cancers—a class of drugs called PARP inhibitors, designed to exploit the very defects that make tumors with certain mutations especially deadly. Yet this targeted approach to cancer therapy sometimes fails, and scientists have anxiously sought to understand why. Now, research at The Rockefeller […]
News that the United States refused to sign — and also reportedly aggressively pressured other countries to back down on — a United Nations-affiliated resolution in support of breastfeeding is making shockwaves across the globe. In a time when “breast is best” and "fed is best" discourses seem to be warring, the news that the […]